Trials / Recruiting
RecruitingNCT07419347
Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data
Retrospective Analysis of Glecaprevir/Pibrentasvir Safety and Concomitant Medications Through Integrated Real-World Data
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the safety, tolerability and effectiveness of 8-week Glecaprevir/Pibrentasvir (G/P) in participants taking either prescribed or illicit drugs.
Conditions
Timeline
- Start date
- 2026-02-27
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2026-02-19
- Last updated
- 2026-04-16
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT07419347. Inclusion in this directory is not an endorsement.